中新网北京12月28日电(阚枫)今日，中国社会科学院经济研究所、社会科学文献出版社在北京联合发布医药蓝皮书——《中国药品市场报告(2012)》。蓝皮书称，2012年中国医药市场规模达到9261亿元，预期到2020年，中国药品市场的规模将达到2.3万亿元。人口老龄化带来药品潜在需求增加。

Beijing Beijing on December and report(KanFeng)today,The Chinese academy of social sciences institute of economy/Social sciences academic press release in the Beijing union medical blue book --[China's drug market report(2012)].Blue book says,In 2012, the Chinese medicine market scale up to 926.1 billion yuan,Expected to 2020,China's drug market scale will reach 2.3 trillion yuan.An aging population brings pharmaceutical potential demand increase.

　　蓝皮书分析了2012年中国药品市场规模和公立医疗机构运营过程中药品的特征，对未来几年的中国药品市场情况进行了预测。

Blue book analysis the 2012 China's drug market scale and public medical institution in the process of operation characteristics of drugs,A few years for the future of Chinese pharmaceutical market is forecasted.

　　蓝皮书指出，中国药品市场呈现出高速扩容、市场竞争激烈、行业集中度低、受政策的影响很大的特点。人口老龄化带来的药品潜在需求增加，经济发展带来的社会保障水平居民购买能力的提升，是药品市场扩张的源泉。国内制药企业随着药品需求同步扩张。外资企业在中国药品市场上扮演着重要角色，尤其是在高端的三级医院药品市场中占据瞩目的市场份额。

Blue book points out that,China's drug market presents high speed flash/Market competition is intense/Industry concentration is low/By the impact of a lot of characteristics.An aging population brings pharmaceutical potential demand increase,With the economic development level of social security of the residents purchase ability of ascension,Is the source of the pharmaceutical market expansion.Domestic pharmaceutical enterprise with drug demand synchronous expansion.The foreign capital enterprise in China pharmaceutical market plays an important role,Especially in the high-end tertiary hospital drug market occupy the market share of the attention.

　　医药蓝皮书指出，中国药品市场呈现以下三个特征。

Medical blue book points out,China's drug market presents the following three characteristics.

　　第一，在人口老龄化及经济发展的双重因素作用下，中国药品市场高速扩容。结合生产、销售终端的各类数据，2005~2010年，中国药品市场的复合增长速度超过20%。

The first,In an aging population and economic development under the action of the double factors,China's drug market high speed flash.Combining with the production/Sales terminal of all kinds of data,2005 ~ 2010,China's drug market compound growth rate of more than 20%.

　　第二，中国药品市场竞争激烈，但国内制药企业并没有很快地实现规模经营，导致行业集中度低。因此，在高端的三级医院药品市场上，外资企业扮演着重要角色。

The second,China's drug market competition is intense,But the domestic pharmaceutical enterprise and not quickly realize scale management,Cause the industry concentration is low.so,In the high-end tertiary hospital pharmaceutical market,The foreign capital enterprise plays an important role.

　　第三，药品市场受政策的影响很大。以基本药物制度为例，由于基层推行的药品销售零差率政策，基层医疗机构药品市场陷入停滞。

The third,By the pharmaceutical market policy influence.To essential drugs system as an example,Due to the implementation of the basic drug sales zero rate policy,Grassroots medical institutions drug markets into stagnation.

　　蓝皮书称，2012年零售终端的药品销售规模为1726亿元，可以计算得出2012年中国药品市场的总规模为9261亿元。

Blue book says,2012 retail terminal drug sales scale for 172.6 billion yuan,Can be calculated in 2012, the Chinese medicine market total scale for 926.1 billion yuan.

　　预期2013～2020年中国药品市场的平均增长达到12%，2013年中国药品市场规模突破1万亿元，2019年中国药品市场规模突破2万亿元；到2020年，中国药品市场的规模将达到2.3万亿元。(完)

Expected 2013 ~ 2020 years Chinese pharmaceutical market average growth of 12%,In 2013, the Chinese medicine market scale hit 1 trillion yuan,In 2019, the Chinese medicine market scale hit 2 trillion yuan;By 2020,China's drug market scale will reach 2.3 trillion yuan.(finish)